Shionogi, Roche get their first approval for the next big thing in fighting the flu
Shionogi has won an approval to sell Xofluza (baloxavir marboxil) in Japan under an accelerated review pathway. And Roche plans to follow up that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
